{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:34:58Z","timestamp":1791059698305,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["20110162120010"],"award-info":[{"award-number":["20110162120010"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2011QNZT151"],"award-info":[{"award-number":["2011QNZT151"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["81170477"],"award-info":[{"award-number":["81170477"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100328"],"award-info":[{"award-number":["81100328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.canlet.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T11:22:20Z","timestamp":1366197740000},"page":"96-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K\/Akt pathway in adult acute leukemia"],"prefix":"10.1016","volume":"336","author":[{"given":"Fang-Fang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-Shu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie-Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2013.04.006_b0005","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/cncr.22189","article-title":"Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol","volume":"107","author":"Hallbook","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2013.04.006_b0010","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199812033392301","article-title":"Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission","volume":"339","author":"Cassileth","year":"1998","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2013.04.006_b0015","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-04-2139","article-title":"Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate","volume":"11","author":"Cortes","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2013.04.006_b0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.26","article-title":"Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia","volume":"22","author":"Steelman","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2013.04.006_b0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/157488810791824485","article-title":"Leukemia stem cells and new strategies to overcome resistance to therapy","volume":"5","author":"Thomas","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.canlet.2013.04.006_b0030","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2013.04.006_b0035","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2013.04.006_b0040","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1073\/pnas.192276999","article-title":"Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo","volume":"99","author":"Zhou","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2013.04.006_b0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/cc.4.2.1406","article-title":"A distinct \u201cside population\u201d of cells in human tumor cells: implications for tumor biology and therapy","volume":"4","author":"Hirschmann-Jax","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2013.04.006_b0050","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood.V98.4.1166","article-title":"A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia","volume":"98","author":"Wulf","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.04.006_b0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2141.2002.03550.x","article-title":"Expression of the BCRP gene (ABCG2\/MXR\/ABCP) in childhood acute lymphoblastic leukaemia","volume":"118","author":"Sauerbrey","year":"2002","journal-title":"Brit. J. Haematol."},{"key":"10.1016\/j.canlet.2013.04.006_b0060","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1182\/blood.V99.10.3763","article-title":"Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia","volume":"99","author":"van der Kolk","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.04.006_b0065","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.leu.2403395","article-title":"Breast cancer resistance protein (BCRP\/MXR\/ABCG2) in acute myeloid leukemia: discordance between expression and function","volume":"18","author":"Suvannasankha","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2013.04.006_b0070","article-title":"The proportion of CD34(+)CD38 (low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia","author":"Roshal","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2013.04.006_b0075","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.2004.02.141","article-title":"The biology and clinical relevance of the PTEN tumor suppressor pathway","volume":"22","author":"Sansal","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2013.04.006_b0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression","volume":"133","author":"Salmena","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2013.04.006_b0085","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2009-06-228130","article-title":"PTEN is a tumor suppressor in CML stem cells and BCR\u2013ABL-induced leukemias in mice","volume":"115","author":"Peng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.04.006_b0090","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2013.04.006_b0095","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1182\/blood-2011-12-399519","article-title":"Inhibition of the mTORC2 and chaperone pathways to treat leukemia","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.04.006_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tips.2010.12.005","article-title":"Non-genomic loss of PTEN function in cancer: not in my genes","volume":"32","author":"Leslie","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2013.04.006_b0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"Bleau","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2013.04.006_b0110","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/stem.192","article-title":"Lack of ABCG2 expression and side population properties in human pluripotent stem cells","volume":"27","author":"Zeng","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.canlet.2013.04.006_b0115","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/nm1297-1337","article-title":"Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species","volume":"3","author":"Goodell","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2013.04.006_b0120","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1158\/1078-0432.CCR-08-0125","article-title":"Targeting the PI3K\/AKT pathway for the treatment of prostate cancer","volume":"15","author":"Sarker","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2013.04.006_b0125","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1158\/0008-5472.CAN-09-4479","article-title":"Targeting fibroblast growth factor receptors blocks PI3K\/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis","volume":"70","author":"Dey","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.04.006_b0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.leu.2404417","article-title":"The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease","volume":"21","author":"Longo","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2013.04.006_b0135","first-page":"445","article-title":"The PI3K\/Akt\/mTOR pathway: a new therapeutic target in the treatment of acute myeloid leukemia","volume":"93","author":"Dos Santos","year":"2006","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.canlet.2013.04.006_b0140","first-page":"277","article-title":"Cancer statistics","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2013.04.006_b0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2013.04.006_b0150","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1158\/1078-0432.CCR-04-1895","article-title":"MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia","volume":"11","author":"Benderra","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2013.04.006_b0155","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1593\/neo.04595","article-title":"MTOR promotes survival and astrocytic characteristics induced by Pten\/AKT signaling in glioblastoma","volume":"7","author":"Hu","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2013.04.006_b0160","doi-asserted-by":"crossref","first-page":"950","DOI":"10.4161\/cbt.11.11.15531","article-title":"The PTEN\/PI3K\/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells","volume":"11","author":"Li","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2013.04.006_b0165","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbrc.2012.03.090","article-title":"PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter","volume":"420","author":"Hegedus","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2013.04.006_b0170","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1182\/blood-2002-01-0271","article-title":"Low levels of ABCG2 expression in adult AML blast samples","volume":"100","author":"Abbott","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.04.006_b0175","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2010.176","article-title":"B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells","volume":"24","author":"Gross","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2013.04.006_b0180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature04703","article-title":"Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells","volume":"441","author":"Yilmaz","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2013.04.006_b0185","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature04747","article-title":"PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention","volume":"441","author":"Zhang","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2013.04.006_b0190","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1101\/gad.1395006","article-title":"The deficiency of Akt1 is sufficient to suppress tumor development in Pten+\/\u2212 mice","volume":"20","author":"Chen","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2013.04.006_b0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/leu.2009.209","article-title":"Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia","volume":"24","author":"Jotta","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2013.04.006_b0200","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.04.006_b0205","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood-2004-03-0954","article-title":"Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia","volume":"104","author":"Roman-Gomez","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.04.006_b0210","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1073\/pnas.0702596104","article-title":"Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513003261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513003261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:34:29Z","timestamp":1759592069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383513003261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0304383513003261"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2013.04.006","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K\/Akt pathway in adult acute leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}